The Retardation of Progression, Stabilization, and Regression of Coronary and Carotid Atherosclerosis by Low-Density Lipoprotein Apheresis in Patients with Familial Hypercholesterolemia

This publication has 28 references indexed in Scilit:

• Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment
  Atherosclerosis, 1996
• Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis
  Thrombosis Research, 1996
• Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance
  Atherosclerosis, 1995
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
  Circulation, 1994
• Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
  The Lancet, 1993
• Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study
  Atherosclerosis, 1992
• Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia
  Atherosclerosis, 1991
• Cholesterol flux in cholesterol ester-loaded macrophages in an in vitro perfusion system
  Atherosclerosis, 1991
• Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia.
  Circulation, 1990
• Plasma exchange and low density lipoprotein apheresis in Watanabe heritable hyperlipidemic rabbits.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987